O. Aktas - Medical Faculty, Heinrich-Heine-University Düsseldorf

基本信息

浏览量：0

职业迁徙

个人简介

暂无内容

研究兴趣

论文共 149 篇作者统计合作学者相似作者

按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选

Rapid Differentiation of MOGAD and MS after a Single Optic Neuritis

T. Pakeerathan,J. Havla,C. Schwake,A. Salmen,M. Ringelstein,O. Aktas,M. Weise, J. A. Gernert,B. Kornek,G. Bsteh,A.-K. Pröbstel,A. Papadopoulou,L. Kulsvehagen, A. B. Ayroza Galvão Ribeiro Gomes, N. Cerdá-Fuertes,F. C. Oertel, A. S. Duchow, F. Paul,J. P. Stellmann, N. Stolowy,K. Hellwig,C. Schneider-Gold,T. Kümpfel, R. Gold,P. Albrecht,I. Ayzenberg

JOURNAL OF NEUROLOGY (2024)

引用0浏览0WOS引用

Regional Grey-Matter A1 Adenosine Receptor Expression in Patients with Early-Stage Multiple Sclerosis: an in Vivo PET Study

V. Schweda, J. Graf,D. Elmenhorst,Andreas Matusch,J. Ingwersen,Bernd Neumaier,O. Aktas, Alexander Bauer,Tina Kroll

Nuklearmedizin/Nuclear-Medizin (2023)

引用0浏览0引用

Characterization of Subclinical Spinal Cord and Optic Nerve MRI Lesions in the N-Momentum Trial

F. Paul, J. Bennett, J. Chen,M. Smith,D. Cimbora,K. Patterson,H. Hartung, H. Kim,K. Fujihara,O. Aktas,B. Cree

EUROPEAN JOURNAL OF NEUROLOGY (2023): 598-599

引用0浏览0引用

Does diroximel fumarate protect against ferroptosis

K. Fischer, L. Thewes, M. Bayer,S. G. Meuth,O. Aktas, C. Berndt

GLIA (2023): E934-E934

引用0浏览0引用

Real-world evidence of ocrelizumab-treated relapsing multiple sclerosis cohort shows changes in progression independent of relapse activity mirroring phase 3 trials

J. Ingwersen,L. Masanneck,M. Pawlitzki,S. Samadzadeh,M. Weise,O. Aktas,S. G. Meuth,P. Albrecht

Scientific Reports（2023）

引用0浏览0WOSNATURE引用

Effect of Inebilizumab on Vaccine-Generated Antibody Titers in NMOSD Participants: Results from N-MOmentum study

H. Hartung,B. Weinshenker,S. Pittock,J. L. Bennett,M. Smith, N. Mittereder,W. A. Rees,D. Cimbora,K. Patterson,F. Paul,R. Marignier,D. Wingerchuk,G. Cutter, A. Green,K. Fujihara,H. Kim, M. Levy,O. Aktas,B. Cree

MULTIPLE SCLEROSIS JOURNAL (2023): 165-165

引用0浏览0引用

Eculizumab use in neuromyelitis optica spectrum disorders: real-world evidence from Germany and Austria

M. Ringelstein,S. Asseyer, G. Lindenblatt, K. Fischer,R. Pul, S. -H. Ozalp,L. Lohmann,K. Giglhuber,V. Haeussler,M. Karenfort,K. Hellwig,F. Paul,J. Bellmann-Strobl,C. Otto,K. Ruprecht,T. Ziemssen,A. Emmer,V. Rothhammer, F. T. Nickel,K. Angstwurm,R. Linker, S. Laurent,C. Warnke,S. Jarius, M. K. Kuhnke,B. Wildemann, S. Wolff,M. Seipelt,Y. Yalachkov,N. Retzlaff,U. K. Zettl,P. Rommer,M. C. Kowarik,J. Wickel,C. Geis,M. W. Huemmert,C. Trebst,M. Senel,L. Klotz,C. Kleinschnitz,S. G. Meuth,O. Aktas,A. Berthele,I. Ayzenberg

MULTIPLE SCLEROSIS JOURNAL（2022）

引用0浏览0引用

P 4 the Impact of Low Affinity Immunoglobulin Gamma Fc Region Receptor III-A Gene Polymorphisms in Neuromyelitis Optica Spectrum Disorder and Implications for Treatment Outcomes: Results from the N-MOmentum Study

J. L. Bennett,B. G. Weinshenker,F. Paul,H-J Kim,O. Aktas,H-P Hartung,J. Drappa,M. Smith,W. A. Rees,D. She,E. Katz,B. A. C. Cree

Clinical neurophysiology (2022): e16-e17

引用1浏览0引用

Efficacy comparison of time to first adjudicated attack with inebilizumab vs satralizumab in NMOSD: a matching-adjusted indirect comparison of monotherapy registrational trials

F. Paul, N. Rampal,D. Cimbora,M. Pedersen,O. Aktas

MULTIPLE SCLEROSIS JOURNAL（2022）

引用0浏览0引用

加载更多

作者统计

合作学者

合作机构

D-Core

合作者
学生
导师

暂无相似学者，你可以通过学者研究领域进行搜索筛选

数据免责声明

页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果，我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问，可以通过电子邮件方式联系我们：report@aminer.cn